drugset / Trial / NCT00065663

Gene Therapy to Improve Wound Healing in Patients With Diabetes

NCT00065663 ↗

Phase 1 Completed 21 enrolled Tissue Repair Company
Non-randomizedFactorialOpen-labelTreatment

Summary

Patients with diabetes may develop chronic wounds that respond poorly to treatment. Gene therapy with the platelet-derived growth factor-B gene has been shown to help with the healing of chronic wounds. This study will evaluate a new way to deliver the gene to the wound tissue.

Timeline

Start
2002-08
Primary completion
—
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject GAM501 Unknown — Topical